Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy

Front Physiol. 2021 Aug 19:12:734320. doi: 10.3389/fphys.2021.734320. eCollection 2021.

Mitchel Tate^{1

2}, Darnel Prakoso^{1

3}, Andrew M Willis¹, Cheng Peng¹, Minh Deo¹, Cheng Xue Qin¹, Jesse L Walsh¹, David M Nash¹, Charles D Cohen¹, Alex K Rofe¹, Arpeeta Sharma⁴, Helen Kiriazis⁵, Daniel G Donner⁵, Judy B De Haan⁴, Anna M D Watson², Miles J De Blasio^{1

3}, Rebecca H Ritchie^{1

2

6}

¹ Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
² Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia.
³ School of Biosciences, The University of Melbourne, Melbourne, VIC, Australia.
⁴ Oxidative Stress Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
⁵ Preclinical Cardiology, Microsurgery and Imaging Platform, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
⁶ Department of Pharmacology and Therapeutics, The University of Melbourne, Melbourne, VIC, Australia.

Abstract

[This corrects the article DOI: 10.3389/fphys.2019.01395.].

Keywords: cardiac; diabetes; diabetic cardiomyopathy; experimental model; type 2 diabetes.